| Synonyms: | |
| Status: | Phase 2 |
| Entry Type: | Oligonucleotide |
| Molecule Category: | UNKNOWN |
| UNII: | 31N550RD05 |
Pharmacology
Indications
| Mesh Heading | Maximum Phase | Mesh ID | Reference |
|---|---|---|---|
| Carcinoma, Squamous Cell | 2 | D002294 | ClinicalTrials |
| Carcinoma, Non-Small-Cell Lung | 2 | D002289 | ClinicalTrials |
| Lymphoma, Large B-Cell, Diffuse | 1 | D016403 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Urinary Bladder Neoplasms | 1 | D001749 | ClinicalTrials |
| Neoplasms | 1 | D009369 | ClinicalTrials |
| Carcinoma, Hepatocellular | 1 | D006528 | ClinicalTrials |
Cross References
| Resources | Reference |
|---|---|
| ChEMBL | CHEMBL4297739 |
| FDA SRS | 31N550RD05 |
CONTENTS